$MANHBearishLow

Manhattan Associates, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. - MANH

Rosen Law Firm said it is investigating potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. (NASDAQ: MANH), according to a June 5, 2026 PRNewswire notice. The firm invited current shareholders to submit information and contact Phillip Kim for details.

8/10
4/10
Low
Bearish
after-hours / late-day PR release (June 5, 2026)
risk-off for MANH on litigation headlines; otherwise limited incremental impact without new case details

This is a shareholder-derivative/litigation risk headline that can pressure sentiment and increase expected legal/settlement costs.

Rosen Law Firm says it is investigating alleged fiduciary-duty breaches by Manhattan Associates’ directors and officers, raising litigation risk.

Near-term downside bias possible on any follow-on filings or escalation; magnitude likely limited unless allegations are substantiated or material.

Background

Rosen Law Firm is announcing it is investigating potential fiduciary-duty breaches by Manhattan Associates’ directors and officers.

Why it matters

Litigation/derivative investigations can increase perceived governance risk and raise tail-risk for valuation, especially if later filings allege financial misstatements, improper disclosures, or misconduct.

Market relevance

Company-specific legal-risk headline for MANH; actionable mainly if it leads to a filed case or additional disclosures.

Market effects

Adds to the broader pattern of investor-rights law firm investigations that can intermittently weigh on software/enterprise-app names via governance risk.

Primarily US-focused equity sentiment for MANH; limited spillover expected absent sector-wide regulator action.

Low—this is company-specific litigation-risk signaling rather than a global operational disruption.

Alternative perspectives

An “investigation” notice is not the same as a lawsuit outcome; absent a filed complaint, market impact may fade quickly.

Traders should watch for subsequent SEC/8-K disclosures, the actual complaint filing, and any named executives/directors to gauge materiality.

Key entities

  • Manhattan Associates, Inc.

    Subject of the alleged fiduciary-duty investigation announced by Rosen Law Firm.

  • Rosen Law Firm

    Investor-rights law firm stating it is investigating potential breaches by MANH directors and officers.

Related articles

$ADSKMed

Analysts’ Updated EPS Estimates for May 29th (ADSK, BBY, BSY, COST, DOO, ENLT, ESTC, FFIV, MANH, MDA)

Analysts updated EPS/ratings for several stocks ahead of May 29. DA Davidson reaffirmed buy ratings for Autodesk ($325) and Best Buy ($78) and reiterated neutral for Costco ($1,000) and buy for MongoDB ($375). Barclays cut Bentley ($49→$40), Elastic ($76→$68), and Manhattan ($239→$201) but raised F5 ($292→$386), Okta ($93→$120), and others; Stifel downgraded BRP to hold ($85).

$MANHMedAI 8/10

Report: Market sentiment for forklift, pallet-handling tech improves

Manhattan Associates said it launched “Sightline,” a new explainability tool within its ActivePlanning suite, to show the “why” behind AI-driven forecasts, orders, and inventory decisions, including inputs like safety stock, vendor minimums, lead times, promotions, and network moves. The company said AI needs human-set rules and guardrails. Separately, Penske Logistics launched “Supply Chain Insight” for unified, real-time transportation and warehousing visibility.

$MANHMed

Vanguard Group Inc. Buys 136,708 Shares of Manhattan Associates, Inc. $MANH

Vanguard Group Inc. increased its stake in Manhattan Associates, Inc. (NASDAQ:MANH) by 2.0% in the fourth quarter, acquiring 136,708 additional shares and now owning 11.55% of the company. Other institutional investors also adjusted their positions in MANH, which reported strong Q4 earnings, beating analyst estimates for both EPS and revenue. The company announced a $500 million stock buyback plan, while analysts maintain a "Moderate Buy" consensus rating with an average target price of $202.91.

$MANHMed

M&T Bank Corp Has $2.90 Million Holdings in Manhattan Associates, Inc. $MANH

M&T Bank Corp significantly increased its stake in Manhattan Associates (NASDAQ:MANH) by 127%, now holding 16,711 shares valued at approximately $2.90 million. Manhattan Associates has shown strong financial performance, beating quarterly expectations and authorizing a $500 million share buyback. Analysts maintain a "Moderate Buy" rating, although some have recently adjusted their price targets.

$MANHMed

Manhattan Associates (NASDAQ:MANH) EVP Sells $1,016,525.00 in Stock

Manhattan Associates (NASDAQ:MANH) Executive Vice President James Stewart Gantt sold 7,300 shares of the company's stock for a total of $1,016,525.00 on April 24th, reducing his holdings by 10.72%. This insider sale follows a strong earnings report where Manhattan Associates beat quarterly estimates, provided positive FY2026 guidance, and authorized a $500 million share repurchase program. Analysts currently maintain a "Moderate Buy" consensus for the stock.